Daewoong Pharmaceutical, Botox (Botulinum Toxin) Theme Rises 8.13%

On the 18th, the Botox (Botulinum Toxin) theme rose 3.09% compared to the previous day, showing strong performance, while Daewoong Pharmaceutical, a related stock drawing attention, surged 8.13% compared to the previous day. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling medicines such as Urusa and Albis.

[Graph] Price Fluctuations of Major Stocks in the Botox (Botulinum Toxin) Theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong Pharmaceutical’s quant financial score is 37.02 points, showing higher growth and stability scores than the average of other stocks related to Botox (Botulinum Toxin), but its quant financial ranking was only 6th out of 9 stocks. On the other hand, Huons Global ranked 1st in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.